000 01643 a2200457 4500
005 20250513090018.0
264 0 _c19960529
008 199605s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI118465
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaton, B C
245 0 0 _aOxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cFeb 1996
300 _a681-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a3-Hydroxyacyl CoA Dehydrogenases
_xdeficiency
650 0 4 _aAustralia
_xepidemiology
650 0 4 _aBile Acids and Salts
_xblood
650 0 4 _aCells, Cultured
650 0 4 _aEnoyl-CoA Hydratase
_xdeficiency
650 0 4 _aFatty Acids
_xblood
650 0 4 _aFibroblasts
_xmetabolism
650 0 4 _aGenetic Complementation Test
650 0 4 _aHumans
650 0 4 _aHybrid Cells
650 0 4 _aIsomerases
650 0 4 _aMicrobodies
_xchemistry
650 0 4 _aMultienzyme Complexes
_xdeficiency
650 0 4 _aOxidation-Reduction
650 0 4 _aPeroxisomal Bifunctional Enzyme
650 0 4 _aPeroxisomal Disorders
_xdiagnosis
650 0 4 _aPhytanic Acid
_xmetabolism
650 0 4 _aPrenatal Diagnosis
650 0 4 _aZellweger Syndrome
_xdiagnosis
700 1 _aSharp, P C
700 1 _aCrane, D I
700 1 _aPoulos, A
773 0 _tThe Journal of clinical investigation
_gvol. 97
_gno. 3
_gp. 681-8
856 4 0 _uhttps://doi.org/10.1172/JCI118465
_zAvailable from publisher's website
999 _c8608269
_d8608269